Women who undergo menopause at or before age forty-five face a statistically significant increase in their risk of developing multiple chronic medical conditions during later life compared to peers reaching menopause at typical ages, according to a harmonized longitudinal study examining thousands of older adults across three continents. The investigation, which analyzed pooled prospective data from major aging cohorts in the United States, England, and Mexico, revealed that the heightened hazard of incident multimorbidity was predominantly concentrated among women who transitioned through reproductive cessation during their earliest reproductive decades. In contrast, women reaching menopause across later age windows exhibited no comparable elevation in cumulative chronic disease risk. By tracking women who initially carried zero or only one pre-existing health condition at baseline, the researchers sought to isolate the initial onset of disease clustering over time, offering fresh epidemiological insights into how early reproductive milestones influence subsequent physiological vulnerability.
Published in Frontiers in Public Health, the collaborative investigation evaluated longitudinal health records from the Health and Retirement Study in the United States, the English Longitudinal Study of Ageing in England, and the Mexican Health and Aging Study in Mexico. Together, these nationally representative and population-based surveys track aging-related physical health, functional status, cognitive performance, and socioeconomic determinants through repeated biennial or periodic evaluations. The analytical sample assembled for this analysis encompassed 6,576 postmenopausal women who reported their exact age at menstrual cessation, possessed no documented record of a prior hysterectomy at baseline, and maintained complete diagnostic records across seven core physician-diagnosed chronic illnesses. Over an aggregate tracking duration of 36,496.1 person-years, reflecting a mean follow-up period of 5.55 years per participant, the research team identified 2,031 new cases of incident multimorbidity, defined specifically as the first survey wave at which an individual accumulated two or more coexisting chronic conditions.
To investigate whether the timing of ovarian cessation influences the rate of systemic disease accumulation, the researchers categorized participant-reported menopausal timing into six standardized strata: forty years or younger, forty-one to forty-five years, forty-six to forty-nine years, fifty to fifty-one years, fifty-two to fifty-three years, and fifty-four years or older. The category spanning fifty to fifty-one years served as the epidemiological reference benchmark because it corresponds to the typical age window of natural menopause observed in broad human populations. Within the analytical cohort of 6,576 women, the sample distribution included 510 women reporting menopause at or before age forty, 930 between ages forty-one and forty-five, 1,219 between forty-six and forty-nine, 1,642 in the reference category of fifty to fifty-one, 1,012 between fifty-two and fifty-three, and 1,263 at age fifty-four or older. Across the total sample, the mean chronological age at baseline entry stood at 61.95 years with a standard deviation of 8.76 years, representing an average interval of 12.67 years between the final menstrual period and baseline survey enrollment.
The study tracked the development of seven specific, participant-reported chronic diseases that had been diagnosed by a physician or health professional: hypertension, diabetes, cancer, chronic pulmonary or respiratory disease, heart disease, stroke, and arthritis or rheumatism. At baseline, all participating women were free of established multimorbidity, with 2,787 participants (42.4 percent) reporting zero conditions and 3,789 participants (57.6 percent) reporting exactly one condition. Among individual baseline conditions across the entire cohort, hypertension was reported by 1,679 women (25.5 percent) and arthritis or rheumatism by 1,403 women (21.3 percent), whereas diabetes was present in 288 women (4.4 percent), cancer in 157 (2.4 percent), heart disease in 128 (1.9 percent), chronic pulmonary conditions in 103 (1.6 percent), and stroke in 31 (0.5 percent). When participants reported a positive diagnosis during follow-up, that diagnosis was permanently carried forward to reflect cumulative medical burden, ensuring that subsequent unrecorded waves did not artificially erase established disease history.
Using Cox proportional hazards regression models with cohort-stratified baseline hazards to accommodate differing background event rates across the United States, England, and Mexico, the investigators estimated hazard ratios for multimorbidity onset across all categories. In the minimally adjusted basic model accounting for baseline chronological age and initial disease count, women with menopause at or before forty years exhibited a hazard ratio of 1.233 (95 percent confidence interval, 1.024 to 1.485), while those reaching menopause between forty-one and forty-five years had a hazard ratio of 1.250 (95 percent confidence interval, 1.079 to 1.449). After comprehensive adjustment for marital or partnered status, continuous body mass index, current smoking, alcohol consumption, standardized depressive symptom scores, and standardized episodic memory word-recall performance, the associations remained robust. The fully adjusted hazard ratios were 1.218 (95 percent confidence interval, 1.052 to 1.410) for menopause at or below forty years and 1.214 (95 percent confidence interval, 1.050 to 1.404) for menopause between forty-one and forty-five years.
Crucially, the elevated hazard of disease accumulation did not display a continuous, linear gradient across the full spectrum of menopausal timing. Instead, the observed risk elevation appeared strictly concentrated among women whose reproductive cycles ceased by age forty-five. For participants transitioning through menopause between forty-six and forty-nine years, the fully adjusted hazard ratio relative to the reference group was 1.043 (95 percent confidence interval, 0.909 to 1.198). Similarly, for women with menopause between fifty-two and fifty-three years, the adjusted hazard ratio was 1.128 (95 percent confidence interval, 0.980 to 1.299), while those with menopause at age fifty-four or older demonstrated a hazard ratio of 1.029 (95 percent confidence interval, 0.903 to 1.174). The authors noted that these findings point toward a threshold-like pattern of long-term vulnerability, where experiencing ovarian cessation substantially earlier than the population norm carries measurable risks, whereas marginal variations around the typical age of fifty do not discernibly alter the trajectory of multimorbidity.
Cohort-specific evaluations confirmed that the main associations observed in the pooled analysis were remarkably consistent across the distinct national populations, despite notable differences in social context, healthcare systems, and survey administration. Among American women in the Health and Retirement Study (comprising 3,756 participants), the fully adjusted hazard ratios were 1.185 (95 percent confidence interval, 1.010 to 1.390) for menopause at or before forty and 1.194 (95 percent confidence interval, 1.021 to 1.396) for ages forty-one to forty-five. In the English Longitudinal Study of Ageing cohort (comprising 787 women), the corresponding hazard ratios were 1.684 (95 percent confidence interval, 1.012 to 2.802) and 1.326 (95 percent confidence interval, 1.006 to 1.748). Within the Mexican Health and Aging Study sample (comprising 2,033 women), the fully adjusted estimates were 1.286 (95 percent confidence interval, 1.014 to 1.632) and 1.302 (95 percent confidence interval, 1.024 to 1.655). Even after additional models incorporated country-specific demographic variables, such as race, ethnicity, and geographic region in the United States, immigrant status in England, and rural versus urban residence in Mexico, point estimates remained elevated with confidence intervals excluding unity.
Further exploratory subgroup evaluations across demographic and behavioral strata revealed that the association between early reproductive cessation and multimorbidity onset persisted across various patient profiles without significant statistical interaction. Tests for effect modification yielded interaction p-values of 0.176 for baseline age, 0.781 for educational attainment, 0.938 for initial disease burden, 0.776 for body mass index, and 0.842 for smoking history. Among participants younger than sixty years at baseline, the association was particularly pronounced, displaying hazard ratios of 1.503 (95 percent confidence interval, 1.132 to 1.995) for menopause at or before forty and 1.352 (95 percent confidence interval, 1.087 to 1.682) for ages forty-one to forty-five. The relationship also remained stable across focused sensitivity models, including analyses restricted to women with zero baseline chronic conditions, individuals whose menopause had occurred within ten years prior to baseline, participants whose repeat menopause reports varied by no more than five years, and models adopting a stricter three-condition multimorbidity threshold.
From a biological perspective, the researchers highlighted several interrelated pathways that plausibly connect prematurely curtailed ovarian function with widespread multi-organ disease development. Natural reproductive cessation marks the permanent depletion of ovarian follicles and a steep drop in endogenous circulating estrogens. Because estrogen exerts regulatory control over vascular endothelial functioning, systemic lipid metabolism, peripheral insulin sensitivity, central adipose deposition, and inflammatory cytokine cascades, an prematurely abbreviated duration of ovarian exposure could expose tissues to decades of adverse metabolic shifts. Over an extended lifespan, these systemic disruptions promote the concurrent development of dysglycemia, hypertension, atherogenic lipid profiles, and chronic low-grade vascular inflammation. The authors also referenced epigenetic findings demonstrating accelerated biological aging markers among women with early menopausal timing, suggesting that premature reproductive cessation may reflect broader systemic biological aging processes that leave individuals vulnerable to concurrent pathologies.
While the study demonstrates a robust longitudinal correlation between early menopause and subsequent multimorbidity, the authors emphasized several methodological constraints inherent to secondary observational research. Foremost, information on menopausal timing and chronic disease onset relied primarily on retrospective participant recollection rather than direct clinical trial observation or real-time medical chart extraction. Furthermore, granular documentation concerning menopausal hormone therapy, bilateral oophorectomy, and the precise physiological reasons for menstrual cessation was unavailable uniformly across all three cohort datasets, preventing their complete harmonization into statistical models. Because exogenous hormone replacement therapy may alleviate certain postmenopausal cardiometabolic consequences, unmeasured prescription variations might have influenced observed associations. Consequently, the investigators emphasized that age at menopause should not serve as an isolated screening tool, but rather as an accessible life-course historical indicator that can alert clinicians to prioritize comprehensive preventive screening for multi-system chronic disease accumulation.
Subject of Research: Association between age at menopause and incident multimorbidity in aging cohorts
Article Title: Earlier age at menopause is associated with incident multimorbidity during later-life follow-up: a harmonized longitudinal analysis of three aging cohorts
Article References: Dai, T.-M., Yuan, J., Ma, Y.-Y., & Liu, J.-J. (2026). Earlier age at menopause is associated with incident multimorbidity during later-life follow-up: a harmonized longitudinal analysis of three aging cohorts. Frontiers in Public Health, 14, Article 1899024. https://doi.org/10.3389/fpubh.2026.1899024
Image Credits: AI Generated
DOI: 10.3389/fpubh.2026.1899024
Keywords: age at menopause, incident multimorbidity, reproductive aging, chronic disease accumulation, Health and Retirement Study, English Longitudinal Study of Ageing, Mexican Health and Aging Study, longitudinal cohort analysis, Cox proportional hazards, postmenopausal women, early menopause, cardiometabolic risk, prospective cohort study, life-course epidemiology, disease accumulation, public health
News Source: Phoebe Ingram. (November 17, 2026). Menopause by Age 45 Linked to Elevated Later-Life Multimorbidity Risk. Scienmag.



